China SXT Pharmaceuticals...
0.42
0.00 (0.41%)
At close: Jan 15, 2025, 10:40 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 1.93M 1.97M 2.60M 4.78M 5.16M 7.01M 7.02M 4.88M 3.72M
Cost of Revenue 1.37M 1.55M 1.35M 1.94M 2.46M 2.40M 3.62M 2.57M 2.92M
Gross Profit 553.97K 426.27K 1.25M 2.84M 2.70M 4.61M 3.40M 2.31M 793.99K
Operating Income -2.52M -5.61M -5.19M -2.20M 4.28M 1.77M 1.63M 1.60M 209.14K
Interest Income n/a 476.78K 36.70K 1.11M 3.35M 5.17K n/a n/a 51.06K
Pretax Income -3.10M -5.93M -5.41M -2.94M -10.39M 1.79M 1.63M 1.58M 188.72K
Net Income -3.10M -5.93M -5.74M -2.75M -10.29M 1.54M 1.19M 1.19M 141.54K
Selling & General & Admin 3.07M 6.03M 6.44M 5.04M 4.04M 2.84M 1.77M 709.82K 584.85K
Research & Development n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses n/a 149.51K -181.58K 871.65K -73.77K 27.14K -3.80K 18.40K n/a
Operating Expenses 3.07M 6.03M 6.44M 5.04M 4.04M 2.84M 1.77M 709.82K 584.85K
Interest Expense 544.28K 476.78K 218.28K 1.62M 3.35M 5.17K 779.00 n/a n/a
Selling & Marketing Expenses 433.57K 387.45K 924.54K 1.59M 1.58M 1.61M 512.48K 144.36K 151.03K
Cost & Expenses 4.44M 7.58M 7.79M 6.97M 6.50M 5.24M 5.39M 3.28M 3.51M
Income Tax n/a 476.78K 328.15K -192.68K -101.72K 252.23K 440.10K 395.05K 47.18K
Shares Outstanding (Basic) 867.42K 266.97K 41.59K 28.78K 12.36K 10.28K n/a n/a n/a
Shares Outstanding (Diluted) 867.42K 266.97K 41.59K 28.78K 12.36K 10.28K n/a n/a n/a
EPS (Basic) -3.57 -22.23 -137.92 -95.48 -832.08 149.67 n/a n/a n/a
EPS (Diluted) -3.57 -22.23 -137.92 -95.48 -832.08 149.67 n/a n/a n/a
EBITDA -2.35M -5.21M -5.05M -1.85M -1.01M 1.95M 1.76M 1.70M 298.11K
Depreciation & Amortization 203.25K 250.16K 320.01K 345.41K 331.84K 180.92K 129.44K 99.23K 88.96K